in membranes industry
Our clients are companies, universities and research institutes.
This project has received funding from the European Union’s EIC Pathfinder Open 2022 programme under grant agreement No. 101115488. The goal of DAM4CO2 is to develop a novel membrane technology for the simultaneous CO2 separation and its photocatalytic conversion to C4+ molecules, as renewable fuels. DAM4CO2 will overcome the conventional membrane technologies by developing double active membranes (DAMs) with a durable and highly selective gas separation layer and a photocatalytic layer able to simultaneously combine in one pot reverse water gas shift (RWGS) and Fisher-Tropsch synthesis (FTS) to obtain C4+ molecules. The project will deliver a prototype, designed using the design-build-test-learn approach, for a proof-of-concept validation in lab-conditions. Close attention will be paid to the use of non-critical raw materials at every stage of the process, and the carbon-neutrality of the entire process will be certified by a full life cycle analysis.
We are a part of INNOMEM Project. Our centrifugal potting system for producing hollow fiber modules is present in INNOMEM catalogue as PL14. Find out more about INNOMEM Project: https://www.innomem.eu.
This project is sponsored by BMBF (Bundesministerium für Bildung und Forschung) and aims at new paths in water management for medical and technical applications. We are establishing innovative methods for waste water-free production through energy-efficient treatment of heavily polluted process water from membrane production.
This project has received funding from the European Union’s EIC Pathfinder Open 2022 programme under grant agreement No. 101099092 and aims at groundbreaking approach for patients with chronic kidney failure. Chronic kidney disease is a worldwide and ever-growing health crisis in which end-stage patients largely depend on intramural dialysis, placing a heavy burden on their life and on European health care systems. KIDNEW develops groundbreaking and modular technology to enable an implantable artificial kidney with better functional kidney replacement therapy (KRT) than currently available, without need for immunosuppressive drugs and at reduced costs.